Mitochondrial oxidative stress and respiratory chain dysfunction account for liver toxicity during amiodarone but not dronedarone administration.
暂无分享,去创建一个
Maurizio Quinto | Anna Maria Giudetti | F. Bellanti | N. Capitanio | G. Gnoni | M. Quinto | Gianluigi Vendemiale | G. Vendemiale | Gaetano Serviddio | Francesco Bellanti | Gabriele Vincenzo Gnoni | Nazzareno Capitanio | Rosanna Tamborra | Antonino Davide Romano | Maria Blonda | Emanuele Altomare | A. Romano | G. Serviddio | A. Giudetti | E. Altomare | R. Tamborra | M. Blonda
[1] Bernhard Kadenbach,et al. Intrinsic and extrinsic uncoupling of oxidative phosphorylation. , 2003, Biochimica et biophysica acta.
[2] R Bracher,et al. Toxicity of amiodarone and amiodarone analogues on isolated rat liver mitochondria. , 2001, Journal of hepatology.
[3] W. Ho,et al. A convenient one-step extraction of cellular ATP using boiling water for the luciferin-luciferase assay of ATP. , 2002, Analytical biochemistry.
[4] J. Sastre,et al. Ursodeoxycholic acid , 2023, Reactions weekly.
[5] N. Parinandi,et al. Assay of cardiolipin peroxidation by high-performance liquid chromatography. , 1988, Chemistry and physics of lipids.
[6] G. Hindricks,et al. Treating arrhythmias: an expert opinion , 2011, Expert opinion on pharmacotherapy.
[7] S. Rabkin. Effect of Amiodarone on Phospholipid Content and Composition in Heart, Lung, Kidney and Skeletal Muscle: Relationship to Alteration of Thyroid Function , 2006, Pharmacology.
[8] M. Portero-Otín,et al. Methionine restriction decreases mitochondrial oxygen radical generation and leak as well as oxidative damage to mitochondrial DNA and proteins , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] F. Bellanti,et al. Bioenergetics in aging: mitochondrial proton leak in aging rat liver, kidney and heart , 2007, Redox report : communications in free radical research.
[10] H. Terada,et al. Uncouplers of oxidative phosphorylation. , 1990, Environmental health perspectives.
[11] P. Heytler. [58] Uncouplers of oxidative phosphorylation , 1979 .
[12] J. Tocanne,et al. Interactions of amiodarone with model membranes and amiodarone-photoinduced peroxidation of lipids. , 1992, Biochemical pharmacology.
[13] L. Siddoway. Amiodarone: guidelines for use and monitoring. , 2003, American family physician.
[14] R. Trohman,et al. Prescribing amiodarone: an evidence-based review of clinical indications. , 2007, JAMA.
[15] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[16] P. Armstrong,et al. Amiodarone hepatotoxicity simulating alcoholic liver disease. , 1984, The New England journal of medicine.
[17] C. J. Sinal,et al. Influence of peroxisome proliferator-activated receptor-alpha (PPARα) activity on adverse effects associated with amiodarone exposure in mice. , 2010, Pharmacological research.
[18] G. Poli,et al. 4-Hydroxynonenal is Markedly Higher in Patients on a Standard Long-term Home Parenteral Nutrition , 2004, Free radical research.
[19] A. Camm,et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, European heart journal.
[20] S. Papa,et al. Cooperative proton-transfer reactions in the respiratory chain: redox bohr effects. , 1986, Methods in enzymology.
[21] R. Houtkooper,et al. Cardiolipin, the heart of mitochondrial metabolism , 2008, Cellular and Molecular Life Sciences.
[22] S. Aust,et al. Microsomal lipid peroxidation. , 1978, Methods in enzymology.
[23] Christopher J Sinal,et al. Disruption of Hepatic Lipid Homeostasis in Mice after Amiodarone Treatment Is Associated with Peroxisome Proliferator-Activated Receptor-αTarget Gene Activation , 2004, Journal of Pharmacology and Experimental Therapeutics.
[24] F. Cuccurullo,et al. Antioxidant activity of amiodarone on human lipoprotein oxidation , 2001, British journal of pharmacology.
[25] M. Ahmad,et al. Molecular mechanisms of N-acetylcysteine actions , 2003, Cellular and Molecular Life Sciences CMLS.
[26] J. Mason. Drug therapy: amiodarone , 1987 .
[27] D. Pessayre,et al. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. , 1998, Gastroenterology.
[28] G. Paradies,et al. Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease. , 2009, Cell calcium.
[29] E. Downar,et al. Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies. , 1984, Gastroenterology.
[30] S. Albert,et al. Effects of amiodarone on serum lipoprotein levels. , 1991, The American journal of cardiology.
[31] L. Siculella,et al. Hypothyroidism down-regulates mitochondrial citrate carrier activity and expression in rat liver. , 2006, Biochimica et biophysica acta.
[32] A. Romano,et al. Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia–reperfusion injury , 2008, Gut.
[33] G. Labbe,et al. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. , 1990, The Journal of pharmacology and experimental therapeutics.
[34] F. Cuccurullo,et al. Amiodarone inhibits tocopherol-mediated human lipoprotein peroxidation. , 2007, Biochemical pharmacology.
[35] D. Pessayre,et al. Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II. , 1990, The Journal of pharmacology and experimental therapeutics.
[36] Martin D. Brand,et al. Body mass dependence of H+ leak in mitochondria and its relevance to metabolic rate , 1993, Nature.
[37] Nihal Ahmad,et al. Dose translation from animal to human studies revisited , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[38] S. Carruthers,et al. Elevation of serum total cholesterol and triglyceride levels during amiodarone therapy. , 1988, The American journal of cardiology.
[39] H. Vieira,et al. Glutathionylation of Adenine Nucleotide Translocase Induced by Carbon Monoxide Prevents Mitochondrial Membrane Permeabilization and Apoptosis* , 2010, The Journal of Biological Chemistry.
[40] A. Campello,et al. Effect of amiodarone (AMD) on the antioxidant enzymes, lipid peroxidation and mitochondrial metabolism , 1997, Cell biochemistry and function.
[41] S. Nattel,et al. New antiarrhythmic drugs for treatment of atrial fibrillation , 2010, The Lancet.
[42] W. J. Dyer,et al. A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.
[43] A. Ghelli,et al. The mechanism of proton and electron transport in mitochondrial complex I. , 1994, Biochimica et biophysica acta.
[44] A. Barrientos. In vivo and in organello assessment of OXPHOS activities. , 2002, Methods.
[45] G. Azzone,et al. The nature of mitochondrial respiration and discrimination between membrane and pump properties. , 1995, The Biochemical journal.
[46] E. Aliot,et al. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. , 2007, The New England journal of medicine.